Director Global Commercial Specialty Care/Biosimilars
Elif Ülkü is a pharmaceutical professional with 6+ years experience in the Specialty Care and Biosimilars industry, having worked in business development, commercial, supply chain, innovation and strategy planning functions across multiple organizations. In her previous roles, Elif led the initiative to define the corporate biotechnology strategy of Turkey’s biggest pharmaceutical company, initiated the company’s first biosimilar development program for global markets, led biosimilar localization projects, established and managed the strategic collaborations with leading biosimilar developers in oncology, immunology and ophthalmology therapy areas. She launched 3 biosimilars in Turkey and EU markets. She actively contributed to the overall public ecosystem in Turkey, presented industry’s needs and solutions to authorities and associations for optimal registration, fair competition, localization and affordability of biosimilars in the country. She currently works in Stada as Director Global Commercial, Specialty Care and Biosimilars.